← Insider Monitor
TRDA
Entrada Therapeutics, Inc.
Recent activity from public SEC and congressional filings.
6
Insider trades
0
Congress trades
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| MPM BioVentures 2014, L.P.Insider | Sell | $200K | 26,522at $7.54 | Aug 25, 2026 |
| MPM BIOVENTURES 2018, L.P.Insider | Sell | $200K | 26,522at $7.54 | Aug 25, 2026 |
| MPM BioVentures 2014, L.P.Insider | Sell | $159K | 21,623at $7.34 | Aug 24, 2026 |
| MPM BIOVENTURES 2018, L.P.Insider | Sell | $159K | 21,623at $7.34 | Aug 24, 2026 |
| MPM BioVentures 2014, L.P.Insider | Sell | $103K | 14,569at $7.06 | Aug 26, 2026 |
| MPM BIOVENTURES 2018, L.P.Insider | Sell | $103K | 14,569at $7.06 | Aug 26, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
No recent congressional disclosures found for TRDA.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable TRDA activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.